BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31324663)

  • 1. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
    Canouï-Poitrine F; Lièvre A; Dayde F; Lopez-Trabada-Ataz D; Baumgaertner I; Dubreuil O; Brunetti F; Coriat R; Maley K; Pernot S; Tournigand C; Hagege M; Aparicio T; Paillaud E; Bastuji-Garin S
    Oncologist; 2019 Dec; 24(12):e1351-e1359. PubMed ID: 31324663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
    Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
    Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World.
    Karim S; Xu Y; Kong S; Abdel-Rahman O; Quan ML; Cheung WY
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e160-e166. PubMed ID: 31133363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
    Freedman RA; Dockter TJ; Lafky JM; Hurria A; Muss HJ; Cohen HJ; Jatoi A; Kemeny MM; Ruddy KJ
    Oncologist; 2018 Sep; 23(9):1016-1023. PubMed ID: 29674441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
    Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
    Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to clinical trials among oncology patients: results of a cross sectional survey.
    Carey M; Boyes AW; Smits R; Bryant J; Waller A; Olver I
    BMC Cancer; 2017 Sep; 17(1):653. PubMed ID: 28923028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
    Eggly S; Senft N; Kim S; Heath EI; Jang H; Moore TF; Baidoun F; Manning MA; Penner LA; Albrecht TL; Carducci MA; Lansey D; Hamel LM
    Cancer Med; 2023 Apr; 12(7):8604-8613. PubMed ID: 36540051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
    Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC Registry.
    Marschner N; Staehler M; Müller L; Nusch A; Harde J; Koska M; Jänicke M; Goebell PJ;
    Clin Genitourin Cancer; 2017 Apr; 15(2):e209-e215. PubMed ID: 27720164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Influencing Participation in Clinical Trials: Emergency Medicine vs. Other Specialties.
    Kurt A; Kincaid HM; Curtis C; Semler L; Meyers M; Johnson M; Careyva BA; Stello B; Friel TJ; Knouse MC; Smulian JC; Jacoby JL
    West J Emerg Med; 2017 Aug; 18(5):846-855. PubMed ID: 28874936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-oncology clinical trial engagement in a nationally representative sample: Identification of motivators and barriers.
    Feuer Z; Matulewicz RS; Basak R; Culton DA; Weaver K; Gallagher K; Hung-Jui Tan ; Rose TL; Milowsky M; Bjurlin MA
    Contemp Clin Trials; 2022 Apr; 115():106715. PubMed ID: 35217187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to clinical trial participation by older women with breast cancer.
    Kemeny MM; Peterson BL; Kornblith AB; Muss HB; Wheeler J; Levine E; Bartlett N; Fleming G; Cohen HJ
    J Clin Oncol; 2003 Jun; 21(12):2268-75. PubMed ID: 12805325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
    Unger JM; Hershman DL; Fleury ME; Vaidya R
    JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.
    Moorcraft SY; Marriott C; Peckitt C; Cunningham D; Chau I; Starling N; Watkins D; Rao S
    Trials; 2016 Jan; 17():17. PubMed ID: 26745891
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.